20/07/2026
👩🔬Some research careers are built on a single question that refuses to let go.
For Dr. Najidh, that question is cutaneous T-cell lymphoma, a rare cancer that affects between 5 and 10 people per million each year, and for which treatment options remain painfully limited.
Trained at Leiden University, where she earned her medical degree and a master's in biomedical sciences, she joined the Department of Dermatology of University Medical Center as a PhD candidate. There, under the supervision of Prof. Maarten Vermeer, she worked on identifying new immunophenotypic and molecular biomarkers for CTCL patients. Her work on improved Sézary cell detection was published in Blood in 2021.
That same year, the René Touraine Foundation supported her long fellowship at Stanford Cancer Institute: "Exploring (epi)genetic mechanisms underlying therapy resistance in cutaneous T-cell lymphoma." The idea was to understand why so many patients relapse after mogamulizumab, and to bridge two of the world's leading cutaneous lymphoma centers, Leiden and Stanford.
Five years later, the bridge holds. At the 6th World Congress on Cutaneous Lymphoma in Montréal, she presented her work on T-cell clonality in CTCL alongside the Stanford team of Prof. Youn Kim and Dr. Michael Khodadoust. She was also this year's recipient of the American Society of Hematology Young Investigator Award, given to a researcher whose cutaneous lymphoma research has been accepted as an ASH abstract.
Research and care, side by side. That is exactly the spirit our foundation wants to support. 🔬